Elevance Health, Inc. $ELV Stock Position Lifted by Valmark Advisers Inc.

Valmark Advisers Inc. increased its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 107.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,605 shares of the company’s stock after buying an additional 1,351 shares during the quarter. Valmark Advisers Inc.’s holdings in Elevance Health were worth $1,013,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ELV. Activest Wealth Management boosted its position in Elevance Health by 146.2% during the 3rd quarter. Activest Wealth Management now owns 64 shares of the company’s stock valued at $25,000 after buying an additional 38 shares during the period. WealthCollab LLC grew its holdings in Elevance Health by 42.2% in the 1st quarter. WealthCollab LLC now owns 91 shares of the company’s stock worth $27,000 after acquiring an additional 27 shares during the last quarter. Kilter Group LLC bought a new stake in Elevance Health in the 2nd quarter worth $28,000. Elevation Wealth Partners LLC raised its stake in shares of Elevance Health by 600.0% during the second quarter. Elevation Wealth Partners LLC now owns 105 shares of the company’s stock valued at $41,000 after acquiring an additional 90 shares during the last quarter. Finally, Tacita Capital Inc purchased a new stake in shares of Elevance Health during the second quarter worth about $44,000. 89.24% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently issued reports on ELV. Wells Fargo & Company raised their target price on Elevance Health from $473.00 to $492.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 27th. Guggenheim raised their price objective on shares of Elevance Health from $460.00 to $485.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Royal Bank Of Canada lifted their price objective on Elevance Health from $424.00 to $455.00 and gave the company a “sector perform” rating in a research report on Thursday, October 22nd. Barclays lifted their price objective on Elevance Health from $469.00 to $472.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Finally, The Goldman Sachs Group reiterated a “neutral” rating and set a $451.00 target price on shares of Elevance Health in a report on Friday, October 23rd. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and an average price target of $456.48.

View Our Latest Stock Analysis on Elevance Health

Elevance Health Trading Down 0.0%

Elevance Health stock opened at $429.50 on Monday. Elevance Health, Inc. has a 12 month low of $274.84 and a 12 month high of $450.69. The company has a market capitalization of $92.80 billion, a price-to-earnings ratio of 18.32, a price-to-earnings-growth ratio of 2.05 and a beta of 0.63. The business’s fifty day simple moving average is $415.40 and its two-hundred day simple moving average is $375.20. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.68.

Elevance Health (NYSE:ELV – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The company reported $6.99 earnings per share for the quarter, beating the consensus estimate of $4.71 by $2.28. The firm had revenue of $50.44 billion during the quarter, compared to the consensus estimate of $49.28 billion. Elevance Health had a return on equity of 14.97% and a net margin of 2.55%. The company’s revenue was up .7% on a year-over-year basis. During the same period last year, the company earned $6.03 earnings per share. As a group, equities analysts predict that Elevance Health, Inc. will post 29.15 earnings per share for the current fiscal year.

Elevance Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be given a dividend of $1.72 per share. This represents a $6.88 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Friday, December 4th. Elevance Health’s dividend payout ratio is 29.34%.

Insider Activity

In related news, EVP Ratnakar Lavu sold 1,300 shares of the stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $440.00, for a total transaction of $572,000.00. Following the sale, the executive vice president directly owned 14,849 shares of the company’s stock, valued at approximately $6,533,560. This represents a 8.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Mark Kaye sold 10,584 shares of the firm’s stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $440.13, for a total transaction of $4,658,335.92. Following the sale, the chief financial officer owned 19,919 shares of the company’s stock, valued at approximately $8,766,949.47. This represents a 34.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.34% of the company’s stock.

About Elevance Health

(Free Report)

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.

See Also

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).

Institutional Ownership by Quarter for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.